Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference

   Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare
                                  Conference

PR Newswire

THOUSAND OAKS, Calif., Sept. 10, 2013

THOUSAND OAKS, Calif., Sept. 10, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
participate in the Bank of America Merrill Lynch Global Healthcare Conference
on Friday, Sept. 13, 2013, in London, beginning at 1:00 p.m. Greenwich Mean
Time. Arvind Sood, vice president of Investor Relations at Amgen, will present
at the conference. Live audio of the presentation can be accessed from the
Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay
of the webcast will also be available on Amgen's website for 90 days following
the event.

About Amgen

Amgen is committed to unlocking the potential of biology for patients
suffering from serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by using tools
like advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics
manufacturing expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer since 1980,
Amgen has grown to be the world's largest independent biotechnology company,
has reached millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Eric Hyllengren, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

SOURCE Amgen

Website: http://www.amgen.com
 
Press spacebar to pause and continue. Press esc to stop.